Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
06/2012
06/21/2012WO2012080472A1 Methods of making cell carrier
06/21/2012WO2012080248A1 Method to generate dopaminergic neurons from mouse and human cells
06/21/2012WO2012079679A1 Dry granulated cell culture media
06/21/2012WO2012079488A1 P28gank monoclonal antibody and peptides for preparation thereof and use thereof
06/21/2012WO2012079278A1 Method for preparing induced pluripotent stem cells and culture medium used for preparing induced pluripotent stem cells
06/21/2012WO2012079142A1 Biopolymer composition for encapsulating cells, method for producing a biopolymer composition for encapsulating cells, method for promoting cell cytoprotection and use of a biopolymer composition for encapsulating cells
06/21/2012WO2012079132A1 Arthroscopy method
06/21/2012WO2012050627A3 Dopaminergic neurons derived from induced pluripotent stem cells and method of making same
06/21/2012WO2012048010A3 Compositions of adult organ stem cells and uses thereof
06/21/2012WO2012046065A3 Culture method for culturing pluripotent cells comprising an inhibitor of mirna- 181a*
06/21/2012WO2012034101A3 Expandable cell source of neuronal stem cell populations and methods for obtaining and using them
06/21/2012WO2012027376A3 Method for expansion of stem cells and the use of such cells
06/21/2012WO2009125999A8 Human host cell for producing recombinant proteins with high quality and quantity
06/21/2012US20120159674 Combined Use of Vip3Ab and Cry1Ab for Management of Resistant Insects
06/21/2012US20120159673 Gene for increasing plant weight and method for using the same
06/21/2012US20120159672 Sequence-determined DNA fragments and corresponding polypeptides encoded thereby
06/21/2012US20120159670 Regulatory Nucleic Acid Molecules for Enhancing Seed-Specific and/or Seed-Preferential Gene Expression in Plants
06/21/2012US20120159667 Variants of nrr activate plant disease resistance
06/21/2012US20120159665 Hybrid tomato ps01544291 and parent lines thereof
06/21/2012US20120159664 Transgenic Plants With Enhanced Agronomic Traits
06/21/2012US20120159663 Pepper hybrid ps09967922
06/21/2012US20120159662 Pepper hybrid ps09979325
06/21/2012US20120159661 T-Bet Compositions and Methods of Use Thereof
06/21/2012US20120159660 Desaturases and methods of using them for synthesis of polyunsaturated fatty acids
06/21/2012US20120159657 Compositions and Methods for Inhibiting Expression of RRM2 Genes
06/21/2012US20120159654 Genome editing of genes involved in adme and toxicology in animals
06/21/2012US20120159653 Genomic editing of genes involved in macular degeneration
06/21/2012US20120157717 Methods and compositions for producing linear alkyl benzenes
06/21/2012US20120157667 Methods Of Producing Humanized Non-Human Mammals
06/21/2012US20120157666 Interferon-like proteins and uses thereof
06/21/2012US20120157665 Gram-positive bacteria specific binding compounds
06/21/2012US20120157663 Antibody identifying an antigen-bound antibody and an antigen-unbound antibody, and method for preparing the same
06/21/2012US20120157662 Means and methods for producing high affinity antibodies
06/21/2012US20120157522 B. Anthracis Prevention and Treatment: Mutant B. Anthracis Lacking Luxs Activity and Furanone Inhibition of Growth, AI-2 Quorum Sensing, and Toxin Production
06/21/2012US20120157514 Oligomeric compounds and compositions for use in modulation of small non-coding rnas
06/21/2012US20120157512 Preventing and Curing Beneficial Insect Diseases Via Plant Transcribed Molecules
06/21/2012US20120157511 5' phosphate mimics
06/21/2012US20120157510 Controlling The Potential Of Primate Neural Stem Cells By Regulating Pax6
06/21/2012US20120157507 USP47 Inhibtors and Methods to Induce Apoptosis
06/21/2012US20120157481 Tricyclic pyrimidine derivatives as wnt antagonists
06/21/2012US20120157474 Methods of Identifying and Using General or Alternative Splicing Inhibitors
06/21/2012US20120157465 Dna methylation inhibitors
06/21/2012US20120157455 Compounds And Compositions For Treating Cancer
06/21/2012US20120157426 Mutant-selective egfr inhibitors and uses thereof
06/21/2012US20120157398 Materials and methods for treating diseases caused by genetic disorders using aminoglycosides and derivatives thereof which exhibit low nephrotoxicity
06/21/2012US20120157384 Mutants pf4 polypeptides exhibiting an increased anti-angiogenic activity
06/21/2012US20120157381 Compositions and methods for cardiac tissue repair
06/21/2012US20120157331 Methods of detecting susceptibility to leukemia/ lymphoma and induction of leukemia and lymphomas
06/21/2012US20120156785 Methods and products for biasing cellular development
06/21/2012US20120156784 Methods for Improving Competency of Plant Cells
06/21/2012US20120156783 Automated liquid manufacturing system
06/21/2012US20120156782 Cell culture medium
06/21/2012US20120156781 Temperature-responsive cell culture substrate on which a straight-chain temperature-responsive polymer is immobilized, and manufacturing method therefor
06/21/2012US20120156780 Polymer Substrates Having Improved Biological Response From HKDCS
06/21/2012US20120156779 Method for cell expansion
06/21/2012US20120156778 Method for efficient production of induced pluripotent stem cells utilizing cells derived from oral mucosa
06/21/2012US20120156777 Cell carrier, associated methods for making cell carrier and culturing cells using the same
06/21/2012US20120156776 Cells Useful for Immuno-Based Botulinum Toxin Serotype A Activity Assays
06/21/2012US20120156775 Cells Useful for Immuno-Based Botulinum Toxin Serotype A Activity Assays
06/21/2012US20120156774 Cells Useful for Immuno-Based Botulinum Toxin Serotype A Activity Assays
06/21/2012US20120156773 Cell carrier, methods of making and use
06/21/2012US20120156772 Cell carrier and methods of making
06/21/2012US20120156771 Functional disruption of an immunoglobulin gene in an avian embryonic stem cell
06/21/2012US20120156770 Human androgen receptor alternative splice variants
06/21/2012US20120156769 Cells Useful for Immuno-Based Botulinum Toxin Serotype A Activity Assays
06/21/2012US20120156755 Polypeptides having cellobiohydrolase activity and polynucleotides encoding same
06/21/2012US20120156751 Preparation and isolation of 5' capped mrna
06/21/2012US20120156749 Separating material and method for collecting cell or the like using the same
06/21/2012US20120156725 Human Anti-OPGL Neutralizing Antibodies As Selective OPGL Pathway Inhibitors
06/21/2012US20120156724 Humanized anti-cd47 antibody
06/21/2012US20120156722 Tumor Suppressor Gene
06/21/2012US20120156713 Method for analyzing and/or treating a fertilized egg, and corresponding system
06/21/2012US20120156704 In vitro method for detecting gp91phox as a marker of oxidative stress
06/21/2012US20120156696 container for forming a cell aggregate and a method for forming a cell aggregate
06/21/2012US20120156695 Microorganism for expressing a human membrane protein
06/21/2012US20120156672 Novel stringent selectable markers
06/21/2012US20120156312 Compositions for Inhibiting Growth of Cancer Stem Cells
06/21/2012US20120156305 Methods for enhancing genome stability and telomere elongation in embryonic stem cells
06/21/2012US20120156254 Recombinant laminin-521
06/21/2012US20120156249 Genetically modified organism for the production of lipids
06/21/2012US20120156246 Reprogramming cancer cells
06/21/2012US20120156241 Rescue of influenza virus
06/21/2012US20120156232 Cancer vaccines and vaccination methods
06/21/2012US20120156231 Foxm1 peptides and vaccines containing the same
06/21/2012US20120156223 Method for Inhibiting Scavenger Receptor-A and Increasing Immune Response to Antigens
06/21/2012US20120156222 Prevention and treatment of alzheimer's disease
06/21/2012US20120156217 Novel EGFR-Binding Molecules and Immunoconjugates Thereof
06/21/2012US20120156210 Methods of treatment using anti-il-22ra antibodies
06/21/2012US20120156207 Methods and compositions for inhibiting cd32b expressing cells
06/21/2012US20120156201 Humanized antibodies specific for hsp65-derived peptide-6 methods and uses thereof
06/21/2012US20120156198 Antibodies against IL-18R1 and uses thereof
06/21/2012US20120156192 Treatment of Diseases and Disorders Using Self-Renewing Colony Forming Cells Cultured and Expanded In Vitro
06/21/2012US20120156181 Therapeutic agent for liver-related diseases
06/21/2012US20120156179 Method for inducing extended self-renewal of functionally differentiated somatic cells
06/21/2012US20120156176 Thermoresponsive, biodegradable, elastomeric material and uses therefor
06/21/2012US20120156175 Composition for inducing migration of neural stem cells containing periostin as effective ingredient
06/21/2012US20120156138 Methods and Compositions for the Treatment of Medical Conditions Involving Cellular Reprogramming
06/21/2012DE102010055287A1 Verfahren und Einrichtung zur Kultivierung und Transport aquatischer Pflanzen Method and apparatus for cultivation and transport of aquatic plants
06/21/2012CA2828794A1 Cell culture medium
06/21/2012CA2826252A1 Recombinant laminin-521